Hyperbaric Oxygen Therapy Shows 0.4% Complication Rate in Large Patient Study

Hyperbaric oxygen therapy has emerged as a valuable treatment for numerous medical conditions, but understanding its safety profile remains crucial for optimal patient care. This comprehensive analysis provides important insights into the complication rates and types of adverse effects associated with this therapeutic approach.

Researchers analyzed patients treated in monoplace hyperbaric chambers between 2009-2010, revealing an overall complication rate of approximately 0.4%. This low incidence demonstrates the generally safe nature of hyperbaric oxygen therapy when properly administered.

The study identified distinct patterns in adverse effects. Ear pain represented nearly half of all complications, while confinement anxiety accounted for about 25% of cases. Complications were categorized into pressure-related issues (barotrauma affecting ears, sinuses, teeth, lungs, and bowel) and oxygen-related effects (pulmonary, neurological, and ophthalmological problems).

Additional considerations include cardiovascular effects like elevated blood pressure and pulmonary edema, metabolic changes such as hypoglycemia, and potential interactions with chemotherapy agents like bleomycin and doxorubicin. The research emphasizes that confinement anxiety, while common, stems from the physical chamber environment rather than the therapy itself.

These findings enable clinicians to better counsel patients about realistic risks and benefits, implement preventive measures where possible, and maintain the high safety standards that make hyperbaric oxygen therapy a viable treatment option for various conditions.